Coagulation factor XI

Coagulation factor XI

Coagulation factor XI Informations sur la molécule

Molecule Name
Coagulation factor XI
Alias de la molécule
Coagulation factor XI,FXI,PTA,F11
Drug Development Progress
Nombre de médicaments cliniques30
Nombre de médicaments commercialisés2
Phase de R&D la plus avancéeApproved
Alias de la cible
EC 3.4.21,EC:3.4.21.27,FXI,F11,PTA,Coagulation Factor XI,Plasma Thromboplastin Antecedent,EC 3.4.21.27,Factor XI,Coagualtion Factor XI
Contexte de la molécule
This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality

Coagulation factor XI Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
AsundexianBAY-2433334Phase 3 ClinicalBayer AG
Atrial Fibrillation; Embolism; Hepatic Insufficiency; Ischemic Attack, Transient; Ischemic Stroke; Myocardial Infarction; Stroke; Thromboembolism
Details
CenvacibartREGN7508Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Atrial Fibrillation; Peripheral Arterial Disease; Thrombosis; Venous Thromboembolism
Details
MilvexianBMS-986177; JNJ-70033093; JNJ-3093Phase 3 ClinicalBristol-Myers Squibb Company
Acute Coronary Syndrome; Atrial Fibrillation; Contraception; Coronary Thrombosis; Embolism; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Renal Insufficiency; Stroke; Thromboembolism; Thrombosis
Details
SHR-2004SHR-2004Phase 3 ClinicalBeijing Suncadia Medicine Co Ltd
Arterial Thromboembolism; Atrial Fibrillation; Dyslipidemias; Thromboembolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis
Details
AmrecibartREGN-9933Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Atrial Fibrillation; Peripheral Arterial Disease; Venous Thromboembolism
Details
AbelacimabMAA-868; NOV-12Phase 3 ClinicalNovartis Pharma Ag
Atrial Fibrillation; Embolism; Neoplasms; Pulmonary Embolism; Stroke; Thromboembolism; Venous Thromboembolism; Venous Thrombosis
Details
EP-7041EP-7041; HSK-36273Phase 2 ClinicalExithera Pharmaceuticals Inc
Blood Coagulation Disorders; Coronavirus Disease 2019 (COVID-19); Kidney Diseases; Thrombocytopenia; Thromboembolism; Thrombosis
Details
OsocimabBAY-1213790Phase 2 ClinicalBayer AG
Kidney Diseases; Kidney Failure, Chronic; Thromboembolism
Details
IONIS-FXIRXISIS-404071; BAY-2306001; ISIS-FXIRX; FXI-ASO; IONIS-FXIRX; ISIS-416858Phase 2 ClinicalIonis Pharmaceuticals Inc
Thrombosis; Venous Thromboembolism
Details
MK-2060MK-2060Phase 2 ClinicalMerck Sharp & Dohme Corp
Kidney Diseases; Kidney Failure, Chronic; Thromboembolism; Thrombosis
Details
SRSD-107SRSD-107; SRSD107Phase 2 ClinicalSirius Therapeutics Inc
Arterial Thromboembolism; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Peripheral Arterial Disease; Thromboembolism; Thrombosis; Venous Thromboembolism
Details
RBD-4059RBD-4059; RBD4059; SR059; SR-059Phase 2 ClinicalSuzhou Ribo Life Science Co Ltd
Coronary Artery Disease; Coronary Disease; Kidney Failure, Chronic; Venous Thrombosis
Details
KN-060KN-060; KN060Phase 2 ClinicalSuzhou Alphamab Co Ltd
Essential Hypertension; Hypertension; Kidney Failure, Chronic; Obesity; Overweight; Thromboembolism
Details
Ir-CPIBIOX-101; Ir-CPIPhase 2 ClinicalFree University Of Brussels
Cerebral Hemorrhage
Details
FesomersenION-957943; IONIS-FXI-LRx; BAY-2976217Phase 2 ClinicalIonis Pharmaceuticals Inc
Nephrosis; Thromboembolism
Details
ONO-7269ONO-7269Phase 1 ClinicalOno Pharmaceutical Co Ltd
Cerebral Infarction
Details
BAY-1831865AB-012; BAY-1831865Phase 1 ClinicalAronora Inc
Thrombosis
Details
A-336A336; A-336Phase 1 ClinicalKlus Pharma
Thromboembolism
Details
A-186A-186Phase 1 ClinicalSichuan Kelun Pharmaceutical Co Ltd
Thromboembolism
Details
BMS-262084BMS-262084Phase 1 ClinicalBristol-Myers Squibb Company
Thrombosis
Details
ADX-626ADX-626Phase 1 ClinicalADARx Pharmaceuticals Inc
Thrombosis
Details
SBK-013SBK013; SBK-013Phase 1 ClinicalChengdu Shibeikang Biomedical Technology Co Ltd
Arterial Thromboembolism; Thromboembolism; Venous Thromboembolism
Details
XH-S002XH-S002; XHS002Phase 1 Clinical
Ischemic Attack, Transient; Stroke
Details
BMS-986209BMS-986209Phase 1 ClinicalBristol-Myers Squibb Company
Details
NIP-003NIP003; NIP-003; CRB4101; CRB-4101Phase 1 ClinicalNational Institutes Of Pharmaceutical Research And Development Co Ltd
Thromboembolism; Venous Thromboembolism; Venous Thrombosis
Details
Factor XIa Inhibitor (Bayer)Factor XIa Inhibitor (Bayer)Phase 1 ClinicalBayer AG
Blood Coagulation Disorders
Details
SKB-336SKB-336Phase 1 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Embolism; Thromboembolism
Details
SAL-0104SAL-0104; SAL0104Phase 1 ClinicalSuzhou Genemen Biotech Co Ltd
Cardiovascular Diseases; Embolism; Ischemic Attack, Transient; Myocardial Infarction; Stroke; Thrombosis; Venous Thromboembolism; Venous Thrombosis
Details
STP122GSTP-122G; STP122GPhase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Embolism and Thrombosis
Details
SHR2285SHR-2285Phase 1 ClinicalJiangsu Hengrui Medicine Co Ltd
Embolism; Thromboembolism; Thrombosis; Venous Thromboembolism
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Factor XI concentrate (factor XI deficiency), CSL BehringApprovedCsl Behring LlcAustraliaFactor XI DeficiencyCsl Behring Llc2014-07-01
Factor XI Deficiency
Details
Human coagulation Factor XI (LFB)ApprovedLfb Biotechnologies SasHemolevenEUFactor XI DeficiencyLfb Biotechnologies Sas1999-07-01
Factor XI Deficiency
Details